astragaloside a has been researched along with Nerve Degeneration in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ding, JH; Du, RH; Hu, G; Xia, ML; Xie, XH | 1 |
| Chan, WS; Durairajan, SS; Koo, I; Kum, WF; Li, M; Lu, JH; Wang, Y; Xie, LX; Yung, KK | 1 |
2 other study(ies) available for astragaloside a and Nerve Degeneration
| Article | Year |
|---|---|
Astragaloside IV inhibits astrocyte senescence: implication in Parkinson's disease.
Topics: Animals; Astrocytes; Cellular Senescence; Dopaminergic Neurons; Male; Mice; Nerve Degeneration; Neuroprotective Agents; Parkinsonian Disorders; Saponins; Triterpenes | 2020 |
Neuroprotective effects of Astragaloside IV in 6-hydroxydopamine-treated primary nigral cell culture.
Topics: Animals; Animals, Newborn; Cell Death; Cell Differentiation; Cells, Cultured; Dopamine; Dose-Response Relationship, Drug; Nerve Degeneration; Neurites; Neurons; Neuroprotective Agents; Nitric Oxide Synthase Type I; Oxidopamine; Parkinson Disease; Rats; Rats, Sprague-Dawley; Saponins; Substantia Nigra; Sympatholytics; Triterpenes; Tyrosine 3-Monooxygenase | 2009 |